Clinical neuro-protection trials in severe traumatic brain injury: Lessons from previous studies

Journal of Neurotrauma

Volumn 14, Issue 2, 1997, Pages 71-80

  Doppenberg, Egon M R ^a   Bullock, Ross ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

clinical trials; end points assessment; mechanism driven; neuroprotection

Indexed keywords

BRAIN INJURY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; NEUROPROTECTION; NEUROTRAUMATOLOGY; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 0030941106     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1997.14.71     Document Type: Review

References (47)

1. ADAMS, J.H., GRAHAM, D.I., and GENARELLI, T.A. (1983). Head injury in man and experimental animals: neuropathology. Acta Neurochir. 32, S15-S30.
2. ADAMS JR, H.P., BROTT, T.G., CROWELL, R.M., ET AL. (1994). Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25, 1901-1914.
3. BOUMA, G.J., MUIZELAAR, J.P., STRINGER, W.A., CHOI, S.C., FATOUROS, P.P., and YOUNG, H.F. (1992). Ultraearly evaluation of regional cerebral blood flow in severely head-injured patients using xenon-enhanced computerized tomography. J. Neurosurg. 77, 360-368.
4. BROADDUS, W.C., PRAHBU, S.S., CHEN, Z.J., LIU, L., FILLMORE, H.L., and GILLIES, G.T. (1996). High-flow microinfusion of c-myc antisense oligonucleotides prolongs survival in an animal model of intracranial malignant glioma. CNS, 46th annual meeting, Montreal (abstract).
5. BULLOCK, R., ZAUNER, A., TSUJI, O., WOODWARD, J.J., MARMAROU, A.T., and YOUNG, H.F. (1995). Patterns of excitatory amino acid release and ionic flux after severe human head trauma, in Neurochemical Monitoring in the Intensive Care Unit. Tsubokawa T., Marmarou A., Robertson C., Teasdale, G. (eds.). Springer-Verlag: Tokyo, pp. 64-77.
6. CLIFTON, G.L., KREUTZER, J.S., CHOI, S.C., DEVANY, C.W., EISENBERG, H.M., FOULKES, M.A., JANE, J.A., MARMAROU, A., and MARSHALL, L.F. (1993). Relationship between Glasgow Outcome Scale and neuropsychological measures after brain injury. Neurosurgery 33, 34-39.
7. DENNY-BROWN, D., and RUSSELL, W.R. (1941). Experimental cerebral concussion. Brain 64, 93-164.
8. DI, X., HARPOLD, T., WATSON, J.C., and BULLOCK, R. (1996). Excitotoxic damage in neurotrauma: fact or fiction. Restorative Neurol. Neurosci. 9, 231-241.
9. DIXON, C.E., LYETH, B.C., and POVLISHOCK, J.T. (1987). A fluid percussion model of experimental brain injury in the rat. J. Neurosurg. 67, 110-119.
10. DRUMMOND, M.F., STODDART, G.L., and TORRANCE, G.W. (1987). Methods for the Economic Evaluation of Health Care Programmes. Oxford Press: Oxford, UK.
11. EISENBERG, H.M., FRANKOWSKI, R.F., CONTANT, C.F., et al. (1988). High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J. Neurosurg. 69, 15-23.
12. GENNARELLI, T.A. (1994). Animal models of human head injury. J. Neurotrauma 4, 357-365.
13. GROSSET, D.G., STRAITON, J., MCDONALD, I., COCKBURN, M., and BULLOCK, R. (1993). Use of transcranial Doppler sonography to predict development of a delayed ischemic deficit after subarachnoid hemorrhage. J. Neurosurg. 78, 183-187.
14. GRUMME, T., BAETHMANN, A., KOLODZIEJCZYK, D., et al. (1995). Treatment of patients with severe head injury by triamcinolone: A prospective, controlled multicenter clinical trial of 396 cases. Res. Exp. Med (Berl.) 195, 217-229.
15. HARDERS, A., KAKARIEZA, A., BRAALMAN, R. (1996). Traumatic subarachnoid hemorrhage and its treatment with nimodipine. German tsah study group. J. Neurosurg. 85, 82-89.
16. KHANDELWAL, S.R., RANDAD, R.S., LIN, P.S., MENG, H., PITTMAN, R.N., KONTOS, H.A., CHOI, S.C., ABRAHAM, D.J., and SMIDT-ULLRICH, R. (1993). Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation. Am. J. Physiol. 265, 1450-1453.
17. LANDOLT, H., LANGEMANN, H., MENDELOWITSCH, A., and GRATZL, O. (1994). Neurochemical monitoring and online pH measurements using brain microdialysis in patients in intensive care. Acta Neurochir. 60, (suppl.) 475-478.
18. LIGHTHALL, I.W. (1988). Controlled cortical impact: a new experimental brain injury model. J. Neurotrauma 6, 83-98.
19. MAIER-HAUFF, K., BAETHMANN, A.J., LANGE, M., SCHURER, L., and UNTERBERG, A. (1984). The kallikrein-kinin system as mediator in vasogenic brain edema. Part 2: Studies on kinin formation in focal and perifocal brain tissue. J. Neurosurg. 61, 97-106.
20. MARION, D.W., OBRIST, W.D., CARLIER, P.M., PENROD, L.E., and DARBY, J.M. (1993). The use of moderate therapeutic hypothermia for patients with severe head injuries: a preliminary report. J. Neurosurg. 79, 354-362.
21. MARION, D.W., LEONOV, Y., GINSBERG, M., KATZ, L.M., KOCHANEK, P.M., LECHLEUTHNER, A., NEMOTO, E.M., OBRIST, W., SAFAR, P., and STERZ, F. (1996). Resuscitative hypothermia. Crit. Care. Med. 24, S81-S89.
22. MARMAROU, A. (1996). Conduct of head injury trials in the United States: The American Brain Injury Consortium (ABIC). Acta Neurochir. 66, (suppl.) 188-121.
23. MARMAROU, A., ANDERSON, R.L., WARD, J.D., CHOI, S.C., and YOUNG, H.F. (1991). NINDS Traumatic Coma Data Bank: intracranial pressure monitoring methodology. J. Neurosurg. 75, S21-S27.
24. MARMAROU, A., FODA, M.A.A.E., VAN DEN BRINK, W. A., ET AL. (1993). A novel impact acceleration model of diffuse axonal injury in the rat. J. Neurotrauma 10, S61.
25. MARSHALL, L.F., MARSHALL, S.B. (1995). Pitfalls and advances from the international tiricazad trial in moderate and severe head injury. J. Neurotrauma 12, 929-932.
26. MCINTOSH, T.K., VINK, R., NOBLE, L., YAMAKAMI, I., FERNYAK, S., and FADEN, A. (1989). Traumatic brain injury in the rat: characterization of a lateral fluid percussion model. Neuroscience 28, 233-244.
27. MUIZELAAR, J.P. (1994). Clinical trials with dismutec (pergorgotein; polyethylene glycol-conjugated Superoxide dismutase; PEG-SOD) in the treatment of severe closed-head injury. Adv. Exp. Med. Biol. 366, 389-400.
28. MUIZELAAR, J.P., MARMAROU, A., YOUNG, H.F., et al. (1993). Improving the outcome of severe head injury with the oxygen radical scavenger. Polyethylene glycol conjugated superoxide dismutase: A phase II trial. J. Neurosurg, 78, 375-382.
29. OMMAYA, A.K., HIRSCH, A.E., FLAMM, E.S., MAHONE, R.H. (1966). Cerebral concussion in the monkey: An experimental model. Science 153, 211-212.
30. PALMER, A.M., MARION, D.W., BOTSCHELLER, M.L., and REDD, E.E. (1993). Therapeutic hypothermia is cytoprotective without attenuating the traumatic brain injury-induced elevations in interstitial concentrations of aspartate and glutamate. J. Neurotrauma. 10, 363-372.
31. PEERLESS, S.J., ISHIWAKA, R., HUNTER, I.G., and PEERLESS, M.J. (1981). Protective effect of Fluosol-DA in acute cerebral ischemia. Stroke 12, 558-563.
32. PETTUS, E.H., CHRISTMAN, C.W., GIEBEL, M.L., and POVLISHOCK, J.T. (1994). Traumatically induced altered permeability: Its relationship to traumatically induced reactive axonal change. J. Neurotrauma. 11, 507-522.
33. POVLISHOCK, J.T., BECKER, D.P., CHENG, C.L.Y., and VAUGHAN, G.W. (1983). Axonal change in minor head injuries. J. Neuropathol. Exp. Neurol. 42, 225-242.
34. RANDAD, R.S., MAHRAN, M.A., MEHANNA, A.S., and ABRAHAM, D.J. (1991). Allosteric modifiers of hemoglobin. 1. design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents. J. Med. Chem. 34, 752-757.
35. SAKAS, D.E., STRANJALIS, G., WHITTAKER, K., and WHITWELL, H.L. (1996). Perfluorochemical oxygen carriers: potential uses in neurosciences. Cerebrovascular and brain metabolism reviews 8, 209-229.
36. SCHWARTZ, M.L., TATOR, C.H., ROWED, D.W., et al. (1984). The University of Toronto head injury treatment Study: A prospective randomized comparison of pentobarbital and mannitol. Can. J. Neurol. Sci. 11, 434-440.
37. STEIN, S.C. (1996) In Neurotrauma. R.K. Narayan, I.E. Wilberger, and J.T. Povlishock (eds.). McGraw-Hill: New York, pp. 755-765.
38. TEASDALE, G., BAILEY, I., BELL, A., et al. (1992). A randomized trial of nimodifine in severe head injury: HITI: British/Finnish Co-operative Head Injury Trial Group. J. Neurotrauma 9, S545-550.
39. TSUCHIDA, E., HARMS, J.F., WOODWARD, J.J., and BULLOCK, R. (1996). A use-dependent sodium channel antagonist, 619C89, in reduction of ischemic brain damage and glutamate release after acute subdural hematoma in the rat. J. Neurosurg. 85, 104-111.
40. UNTERBERG, A., and BAETHMANN, A.J. (1984). The kallikrein-kinin system as mediator in vasogenic brain edema. Part 1 : cerebral exposure to bradykinin and plasma. J. Neurosurg. 61, 87-96.
41. UNTERBERG, A., DAUTERMANN, C., BAETHMANN, A., and MULLER-ESTERI, W. (1986). The kallikrein-kinin system as mediator in vasogenic brain edema. Part 3: Inhibition of the kallikrein-kinin system in traumatic brain swelling. J. Neurosurg. 61, 269-276.
42. WARD, J.D., BECKER, D.P., MILLER, J.D., et al. (1985). Failure of prophylactic barbiturate coma in the treatment of severe head injury. J. Neurosurg. 62, 383-388.
43. 2 saturation of hemoglobin on cerebral vasodilatation from hypoxia and hypotension. Am. J. Physiol. 265, 1439-1443.
44. WHITEHEAD, J. (1983). The Design and Analysis of Sequential Clinical Trials. Halsted Press: New York.
45. WOLF, A.L., LEVI, L., MARMAROU, A., et al. (1993). Effect of tham upon outcome in severe head injury: A randomized prospective clinical trial. J. Neurosurg. 78, 54-59.
46. 2, pH, and temperature monitoring: evaluation in the feline brain. Neurosurgery 37, 1168-1177.
47. ZAUNER, A., DOPPENBERG, E.M.R., WOODWARD, J.J., et al. (1997). Continuous multiparameter monitoring of substrate delivery and brain metabolism: Initial experience in 24 patients with severe acute brain injury. In submission.